The KCNJ2 Knockout A2780 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout population derived from the A2780 human ovarian carcinoma cell line, engineered to disrupt the KCNJ2 gene encoding the inwardly rectifying potassium channel Kir2.1. Unlike monoclonal knockout lines, this polyclonal pool contains a heterogeneous mixture of edited alleles, minimizing the risk of clonal artifacts and better reflecting the genetic diversity inherent in tumor cell populations. This loss-of-function model enables robust investigation of Kir2.1-dependent processes without introducing biases from single-cell selection, making it an ideal choice for studying ion channel roles in cancer biology.
The A2780 cell line originates from a patient with high-grade serous ovarian carcinoma, the most prevalent and lethal subtype of epithelial ovarian cancer. A2780 cells retain key characteristics of the disease, including epithelial morphology and genomic instability, and are widely employed in drug discovery, chemoresistance studies, and signal transduction research. By integrating KCNJ2 knockout into this clinically relevant background, researchers can directly probe the contribution of potassium channels to ovarian tumorigenesis and therapeutic response.
KCNJ2 encodes Kir2.1, a strong inward rectifier potassium channel that assembles as a tetramer to set the resting membrane potential and regulate cellular excitability. Channel activity is tightly controlled by intracellular regulators including phosphatidylinositol 4,5-bisphosphate (PIP2), protein kinases PKA and PKC, G-proteins, magnesium, and polyamines. Kir2.1 interacts with scaffolding proteins MAGI-1, DLG1 (SAP97), CASK, and LIN7, and heteromerizes with Kir2.2 (KCNJ12) and Kir2.3 (KCNJ4) to fine-tune current properties. Downstream, Kir2.1 governs membrane potential, intracellular calcium flux, ERK1/2 phosphorylation, and cell cycle progression. In A2780 cells, KCNJ2 disruption collapses potassium homeostasis, provoking membrane depolarization and dysregulating G-protein-coupled receptor cascades via G?¦? subunits and adenylate cyclase/cAMP, ultimately rewiring pro-proliferative signaling networks.
Depolarization of the resting membrane potential in A2780 cells due to Kir2.1 loss alters the driving force for calcium entry, potentially modulating calcium-dependent kinases and transcription factors that orchestrate cell growth and survival. This positions Kir2.1 as a molecular link between membrane excitability and oncogenic signaling in ovarian cancer. The polyclonal knockout design ensures that the observed phenotypes represent population-averaged effects, avoiding the confounding influence of clonal adaptation and providing a more physiologically relevant model for studying ion channel dysregulation in cancer.
The KCNJ2 Knockout A2780 Polyclonal Cells support a wide range of experimental techniques, including patch clamp electrophysiology for direct measurement of potassium currents, western blotting and immunofluorescence for Kir2.1 expression analysis, cell proliferation assays (MTT, BrdU), membrane potential assessment using voltage-sensitive dyes or FLIPR, and RT-qPCR for gene expression profiling. This model is instrumental for research into cardiac arrhythmias, Andersen-Tawil syndrome, and familial periodic paralysis, and serves as a screening platform for ion channel modulators. For further technical assistance, please contact Ascent Research.
